• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

982
82
61
58
47

COUNTRY

56
19
10
6
5

CATEGORIES

  • 82
  • 120
  • 66
  • 66
  • 36
  • 37
  • 11
  • 11
  • 12
  • 18

PRICE

550
813
1,789
2,612

PUBLISHED

57
238
680
2,612

PRODUCT TYPE

2,461
76
62
12
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE
Zometa Concentrate-Drug Insights,2014 Zometa Concentrate-Drug Insights,2014 - Product Thumbnail Image

Zometa Concentrate-Drug Insights,2014

“Zometa Concentrate - Drug Insights, 2014” provides Zometa Concentrate marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates...

February 2015
FROM
Neupogen-Drug Insights,2014 Neupogen-Drug Insights,2014 - Product Thumbnail Image

Neupogen-Drug Insights,2014

“Neupogen - Drug Insights, 2014” provides Neupogen marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

February 2015
FROM
Drug Delivery in Cancer - Technologies, Markets and Companies Drug Delivery in Cancer - Technologies, Markets and Companies - Product Thumbnail Image

Drug Delivery in Cancer - Technologies, Markets and Companies

Drug delivery remains a challenge in management of cancer. Approximately 12.5 million new cases of cancer are being diagnosed worldwide each year and considerable research is in progress for drug discovery...

February 2015
FROM
The Market for In Vitro Diagnostic Tests in Latin America (Colombia, Brazil, Peru, Argentina, Chile, Venezuela, Ecuador and Other Nations) The Market for In Vitro Diagnostic Tests in Latin America (Colombia, Brazil, Peru, Argentina, Chile, Venezuela, Ecuador and Other Nations) - Product Thumbnail Image

The Market for In Vitro Diagnostic Tests in Latin America (Colombia, Brazil, Peru, Argentina, Chile, Venezuela, Ecuador and Other Nations)

The maturation of IVD markets in developed countries has IVD companies casting their nets in developing countries where rising incomes and standards of living are anticipated to spark a new health consciousness...

January 2015
FROM

Leiomyosarcoma - Pipeline Review, H1 2015

Leiomyosarcoma - Pipeline Review, H1 2015 Summary This, ‘Leiomyosarcoma - Pipeline Review, H1 2015’, provides an overview of the Leiomyosarcoma’s therapeutic pipeline. This report provides comprehensive...

January 2015
FROM

Brain Cancer - Pipeline Review, H1 2015

Brain Cancer - Pipeline Review, H1 2015 Summary This, ‘Brain Cancer - Pipeline Review, H1 2015’, provides an overview of the Brain Cancer’s therapeutic pipeline. This report provides comprehensive...

January 2015
FROM

Oral Mucositis - Pipeline Review, H1 2015

Oral Mucositis - Pipeline Review, H1 2015 Summary This, ‘Oral Mucositis - Pipeline Review, H1 2015’, provides an overview of the Oral Mucositis’s therapeutic pipeline. This report provides comprehensive...

January 2015
FROM

Chemotherapy Induced Neutropenia - Pipeline Review, H1 2015

Chemotherapy Induced Neutropenia - Pipeline Review, H1 2015 Summary This, ‘Chemotherapy Induced Neutropenia - Pipeline Review, H1 2015’, provides an overview of the Chemotherapy Induced Neutropenia’s...

January 2015
FROM

Hodgkin Lymphoma - Pipeline Review, H1 2015

Hodgkin Lymphoma - Pipeline Review, H1 2015 Summary This, ‘Hodgkin Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Hodgkin Lymphoma’s therapeutic pipeline. This report provides...

January 2015
FROM

Peritoneal Cancer - Pipeline Review, H1 2015

Peritoneal Cancer - Pipeline Review, H1 2015 Summary This, ‘Peritoneal Cancer - Pipeline Review, H1 2015’, provides an overview of the Peritoneal Cancer’s therapeutic pipeline. This report provides...

January 2015
FROM

Metastatic Pancreatic Cancer - Pipeline Review, H1 2015

Metastatic Pancreatic Cancer - Pipeline Review, H1 2015 Summary This, ‘Metastatic Pancreatic Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Pancreatic Cancer’s therapeutic...

January 2015
FROM

Nasopharyngeal Cancer - Pipeline Review, H1 2015

Nasopharyngeal Cancer - Pipeline Review, H1 2015 Summary This, ‘Nasopharyngeal Cancer - Pipeline Review, H1 2015’, provides an overview of the Nasopharyngeal Cancer’s therapeutic pipeline. This report...

January 2015
FROM

Recurrent Malignant Glioma - Pipeline Review, H1 2015

Recurrent Malignant Glioma - Pipeline Review, H1 2015 Summary This, ‘Recurrent Malignant Glioma - Pipeline Review, H1 2015’, provides an overview of the Recurrent Malignant Glioma’s therapeutic pipeline. This...

January 2015
FROM

Paraganglioma (Glomus Jugulare Tumor) - Pipeline Review, H1 2015

Paraganglioma (Glomus Jugulare Tumor) - Pipeline Review, H1 2015 Summary This, ‘Paraganglioma (Glomus Jugulare Tumor) - Pipeline Review, H1 2015’, provides an overview of the Paraganglioma (Glomus...

January 2015
FROM

Follicular Thyroid Cancer - Pipeline Review, H1 2015

Follicular Thyroid Cancer - Pipeline Review, H1 2015 Summary This, ‘Follicular Thyroid Cancer - Pipeline Review, H1 2015’, provides an overview of the Follicular Thyroid Cancer’s therapeutic pipeline. This...

January 2015
FROM

Metastatic Prostate Cancer - Pipeline Review, H1 2015

Metastatic Prostate Cancer - Pipeline Review, H1 2015 Summary This, ‘Metastatic Prostate Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Prostate Cancer’s therapeutic pipeline. This...

January 2015
FROM

Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2015

Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2015 Summary This, ‘Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Metastatic Renal Cell Carcinoma’s...

January 2015
FROM

Malignant Glioma - Pipeline Review, H1 2015

Malignant Glioma - Pipeline Review, H1 2015 Summary This, ‘Malignant Glioma - Pipeline Review, H1 2015’, provides an overview of the Malignant Glioma’s therapeutic pipeline. This report provides...

January 2015
FROM

Breast Cancer - Pipeline Review, H1 2015

Breast Cancer - Pipeline Review, H1 2015 Summary This, ‘Breast Cancer - Pipeline Review, H1 2015’, provides an overview of the Breast Cancer’s therapeutic pipeline. This report provides comprehensive...

January 2015
FROM

Anaplastic Thyroid Cancer - Pipeline Review, H1 2015

Anaplastic Thyroid Cancer - Pipeline Review, H1 2015 Summary This, ‘Anaplastic Thyroid Cancer - Pipeline Review, H1 2015’, provides an overview of the Anaplastic Thyroid Cancer’s therapeutic pipeline. This...

January 2015
FROM
Loading Indicator

Our Clients

Photocure ASA Roche Diagnostics Ltd. Abbott Laboratories Ltd. Pfizer, Inc. Novartis AG Becton, Dickinson and Company (BD)